|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?显示文摘AIM:To investigate the prevalence of gastroesophageal reflux disease(GERD) in patients with a laryngoscopic diagnosis of laryngopharyngeal reflux(LPR).METHODS:Between May 2011 and October 2011,41 consecutive patients with laryngopharyngeal symptoms(LPS) and laryngoscopic diagnosis of LPR were empirically treated with proton pump inhibitors(PPIs) for at least 8 wk,and the therapeutic outcome was assessed through validated questionnaires(GERD impact scale,GIS;visual analogue scale,VAS).LPR diagnosis was performed by ear,nose and throat specialists using the reflux finding score(RFS) and reflux symptom index(RSI).After a 16-d wash-out from PPIs,all patients underwent an upper endoscopy,stationary esophageal manometry,24-h multichannel intraluminal impedance and pH(MII-pH) esophageal monitoring.A positive correlation between LPR diagnosis and GERD was supposed based on the presence of esophagitis(ERD),pathological acid exposure time(AET) in the absence of esophageal erosions(NERD),and a positive correlation between symptoms and refluxes(hypersensitive esophagus,HE).RESULTS:The male/female ratio was 0.52(14/27),the mean age ± SD was 51.5 ± 12.7 years,and the mean body mass index was 25.7 ± 3.4 kg/m 2.All subjects reported one or more LPS.Twenty-five out of 41 patients also had typical GERD symptoms(heartburn and/or regurgitation).The most frequent laryngoscopic findings were posterior laryngeal hyperemia(38/41),linear indentation in the medial edge of the vocal fold(31/41),vocal fold nodules(6/41) and diffuse infraglottic oedema(25/41).The GIS analysis showed that 10/41 patients reported symptom relief with PPI therapy(P < 0.05);conversely,23/41 did not report any clinical improvement.At the same time,the VAS analysis showed a significant reduction in typical GERD symptoms after PPI therapy(P < 0.001).A significant reduction in LPS symptoms.On the other hand,such result was not recorded for LPS.Esophagitis was detected in 2/41 patients,and ineffective esophageal motility was found in 3/41 patients.The MII-pH analysis showed an abnormal AET in 5/41 patients(2 ERD and 3 NERD);11/41 patients had a normal AET and a positive association between symptoms and refluxes(HE),and 25/41 patients had a normal AET and a negative association between symptoms and refluxes(no GERD patients).It is noteworthy that HE patients had a positive association with typical GERD-related symptoms.Gas refluxes were found more frequently in patients with globus(29.7 ± 3.6) and hoarseness(21.5 ± 7.4) than in patients with heartburn or regurgitation(7.8 ± 6.2).Gas refluxes were positively associated with extraesophageal symptoms(P < 0.05).Overall,no differences were found among the three groups of patients in terms of the frequency of laryngeal signs.The proximal reflux was abnormal in patients with ERD/NERD only.The differences observed by means of MII-pH analysis among the three subgroups of patients(ERD/NERD,HE,no GERD) were not demonstrated with the RSI and RFS.Moreover,only the number of gas refluxes was found to have a significant association with the RFS(P = 0.028 andP = 0.026,nominal and numerical correlation,respectively).CONCLUSION:MII-pH analysis confirmed GERD diagnosis in less than 40% of patients with previous diagnosis of LPR,most likely because of the low specificity of the laryngoscopic findings. | Nicola de Bortoli Andrea Nacci Edoardo Savarino Irene Martinucci Massimo Bellini Bruno Fattori Linda Ceccarelli Francesco Costa Maria Gloria Mumolo Angelo Ricchiuti Vincenzo Savarino Stefano Berrettini Santino Marchi | 2012 | World Journal of Gastroenterology2012，18，32： | 11 |
| 2 | Treatment of laryngopharyngeal reflux disease: A systematic review显示文摘BACKGROUNG For a long time,laryngopharyngeal reflux disease(LPRD)has been treated by proton pump inhibitors(PPIs)with an uncertain success rate.AIM To shed light the current therapeutic strategies used for LPRD in order to analysis the rationale in the LPRD treatment.METHODS Three authors conducted a PubMed search to identify papers published between January 1990 and February 2019 about the treatment of LPRD.Clinical prospective or retrospective studies had to explore the impact of medical treatment(s)on the clinical presentation of suspected or confirmed LPRD.The criteria for considering studies for the review were based on the population,intervention,comparison,and outcome framework.RESULTS The search identified 1355 relevant papers,of which 76 studies met the inclusion criteria,accounting for 6457 patients.A total of 64 studies consisted of empirical therapeutic trials and 12 were studies where authors formally identified LPRD with pH-monitoring or multichannel intraluminal impedance-pH monitoring(MII-pH).The main therapeutic scheme consisted of once or twice daily PPIs for a duration ranged from 4 to 24 wk.The most used PPIs were omeprazole,esomeprazole,rabeprazole,lansoprazole and pantoprazole with a success rate ranging from 18%to 87%.Other composite treatments have been prescribed including PPIs,alginate,prokinetics,and H2 Receptor antagonists.CONCLUSION Regarding the development of MII-pH and the identification of LPRD subtypes(acid,nonacid,mixed),future studies are needed to improve the LPRD treatment considering all subtypes of reflux. | Jerome R Lechien Francois Mouawad Maria R Barillari Andrea Nacci Seyyedeh Maryam Khoddami Necati Enver Sampath Kumar Raghunandhan Christian Calvo-Henriquez Young-Gyu Eun Sven Saussez | 2019 | World Journal of Clinical Cases2019，7，19： | 9 |
| 3 | Tuberculosis and other infections in the anti-tumour necrosis factor-alpha (anti-TNF-ct) era显示文摘 | Nacci F Matucci-Cerinic M | 2011 | Best Pract Res Clin Rheumatol2011，25，3： | 1 |
| 4 | Endothelial dys- function in diabetes: from mechanisms to therapeutic targets 显示文摘 | Potenza MA Gagliardi S Nacci C | 2009 | Curr Med Chem2009，16，6： | 1 |
| 5 | Sudden hypoacusis treated with hyperbaric oxygen therapy: a controlled study显示文摘 | Fattori B Berrettini A Nacci A | 2001 | ENT2001，88，： | 1 |
| 6 | The role of 99Tcm-tetrofosmin scintigraphy for staging patients with laryngeal cancer显示文摘 | Fattori B Grosso M Nacci A | 2005 | Cancer Biother Radiopharm2005，20，1： | 1 |
| 7 | Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets显示文摘 | Potenza MA Gagliardi S Nacci C | 2009 | Curr Med Chem2009，16，1： | 1 |
| 8 | Globular adiponectin counteracts VCAM-1-mediated monocyte adhesion via AdipoR1/NF-kappaB/COX-2 signaling in human aortic endothelial cells显示文摘 | Addabbo F Nacci C De Benedictis L | 2011 | Am J Physiol Endocrinol Metab2011，301，6： | 1 |
| 9 | Antibodies to inner ear antigens in Meniere's disease显示文摘 | Riente L Bongiomi F Nacci A | 2004 | Clin Exp Immunol2004，135，1： | 1 |
| 10 | Antibodies to inner ear antigens in Meniere's disease显示文摘 | Riente L Bongiorni F Nacci A | 2004 | Clin Exp Immunol2004，135，： | 1 |
| 11 | Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets 显示文摘 | Potenza MA Gagliardi S Nacci C | 2009 | Curr Med Chem2009，16，： | 1 |
| 12 | Nondestructive indicator of ethoxyresorufin-O-deethylase acting in embryonic fish 显示文摘 | Nacci DN Coiro L Kuhn A | 1998 | Environ Toxicol Chem1998，17，12： | 1 |
| 13 | Pd- bemothiazole earbene catalyzed earbonylation of aryl halides in ionic liquids显示文摘 | CALO V GIANNOCCARO P NACCI A | 2002 | Journal of Organometallic Chemistry2002，645，12： | 1 |
| 14 | Pd-benzothiazole carbene catalysed carbonylation of aryl halides in ionic liquids 显示文摘 | CALO V GIANNOCCARO P NACCI A | 2002 | J Organomet Chem2002，645，12： | 1 |
| 15 | Sudden hypoacusis treated with hyperbaric oxygen therapy:a controlled study显示文摘 | Fattori B Berrettini A Nacci A | 2001 | ENT2001，88，： | 1 |
| 16 | Sudden hypoacusis treated with hyperbaric oxygen therapy:a controlled study显示文摘 | Fattori B Berrettini A Nacci A | 2001 | ENT2001，88，： | 1 |
| 17 | New antipsychotic agents with serotonin and dopamine antagonist properties based on a pyrrolobenzothiazepine structure显示文摘 | CAMPIANI G NACCI V BECHELLI S | 1998 | J Med Chem1998，41，20： | 1 |
| 18 | Endothelial dys- function in diabetes:from mechanisms to therapeutic tar- gets 显示文摘 | Potenza MA Gagliardi S Nacci C | 2009 | Current Medicinal Chemistry2009，16，1： | 1 |
| 19 | Molecular and clinical aspects of endothelial dysfunction in diabetes显示文摘 | Nacci C Tarquinio M Montagnani M | | 0，，02： | 1 |
| 20 | Molecular and clini- cal aspects of endothelial dysfunction in diabetes 显示文摘 | Nacci C Tarquinio M Montagnani M | 2009 | In- tern Emerg Med2009，4，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员